GlassScriptPhysician profile
Tiffany Lopez
NPI 1790459212
$886.76
in general payments reported to CMS, 2019-2025
16 companies · $106 in 2025
The $106 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $121 · 2022: $313 · 2023: $81.59 · 2024: $265 · 2025: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $452.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $318.12 | 2022-2025 | |
| Lilly USA, LLC | $84.19 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $81.83 | 2021-2022 | |
| Melinta Therapeutics, LLC | $75.25 | 2024 | Rezzayo, Kimyrsa, Vabomere |
| Viiv Healthcare Company | $50.16 | 2024-2025 | Cabenuva, Dovato |
| Aimmune Therapeutics, INC. | $42.16 | 2025 | Vowst |
| Novo Nordisk INC | $39.04 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $38.84 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $36.13 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $28.24 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.04 | 2021 | |
| Paratek Pharmaceuticals, INC. | $17.08 | 2023 | Nuzyra |
| Otsuka America Pharmaceutical, INC. | $15.88 | 2022 | |
| Alnylam Pharmaceuticals INC. | $15.18 | 2021 | |
| Glaxosmithkline, LLC. | $13.79 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $12.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffany Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.